Felipe Bueno

About

Felipe Bueno is a clinical researcher whose work focuses on improving the diagnostic accuracy of infectious disease testing, particularly for SARS-CoV-2. His most cited study, “Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens” (2020, 11 citations), addresses a critical challenge in COVID-19 diagnosis: the high rate of false-negative RT-PCR results. Bueno’s research introduces a novel method using the human β-glucuronidase gene as an internal control to verify specimen quality and test validity, thereby reducing diagnostic errors. This contribution is vital for clinicians and epidemiologists relying on accurate testing for patient management and public health surveillance. By tackling the issue of up to 30% of suspected cases yielding initial negative results, Bueno’s work enhances the reliability of molecular diagnostics during pandemics. His findings have practical implications for laboratory protocols and underscore the importance of rigorous quality control in viral detection. Bueno’s research stands out for its direct impact on improving clinical decision-making and outbreak control strategies.

Research Focus

Key Achievements

Top Papers

1. 1
   Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens

   11 citations · 2020

Key Collaborators

Contact & Links